retatrutide triple agonist obesity trial isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and Drug retatrutide phase 2 trial obesity

This metabolic slowdown reduces heat production, making you feel colder even in temperatures that previously felt comfortable

USA 106 , 27882793 (2009)

1 (the Budget Reconciliation Act of 2025) take effect

Symptoms such as jaundice, acute abdominal pain, or altered mental status require urgent medical assistance

Budgeting for the new therapy remains a huge challenge, but with emerging evidence and pricing dynamics, plan sponsors should revisit older cost-benefit analyses

Each of our articles is carefully reviewed and curated with interviews and opinions from medical experts, public health officials, and experienced administrators